Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Meda

This page shows the latest Meda news and features for those working in and with pharma, biotech and healthcare.

Mylan agrees to buy Sweden's Meda for $7.2bn

Mylan agrees to buy Sweden's Meda for $7.2bn

After the deal goes through, the Mylan/Meda OTC business will have sales of around $1bn per year, a sizeable tally in a market that despite consolidation remains highly fragmented. ... Adding Meda enhances Mylan's presence in attractive markets such as

Latest news

  • Meda collaborates on asthma comic book Meda collaborates on asthma comic book

    Launches new Explain Asthma volume at ACAAI annual meeting. Meda and Medikiz have launched a new volume in a series of educational healthcare comic books for children. ... Asked why Meda chose to become involved in this project, Loesch said: “ Asthma

  • Cancer drugs lead SMC recommendations Cancer drugs lead SMC recommendations

    People with acne also have access to another treatment after the positive recommendation for Meda Pharmaceuticals' Treclin (clindamycin / tretinoin), while the SMC also gave the green light to the orphan drug

  • Meda agrees $3.1bn takeover of Italy's Rottapharm Meda agrees $3.1bn takeover of Italy's Rottapharm

    Meda said this morning the deal would expand its portfolio of specialty prescription drugs and consumer healthcare products, while also helping it to expand in emerging markets. ... which complement Meda's own operations in countries such as China and

  • Sanofi won't take part in mega-deal trend Sanofi won't take part in mega-deal trend

    Meanwhile, rising Canadian company Valeant is also said to be interested in a $45bn merger with Allergan and generics firm Mylan is attempting to buy Swedish company Meda for $9bn.

  • Mylan raises offer for Meda to $9bn Mylan raises offer for Meda to $9bn

    The board's decision is based on a strong belief in the continued potential of Meda as a stand-alone company," said Meda in a statement issued this morning. ... Mylan's offer could be undermined by the reticence of one of its own shareholders, however,

More from news
Approximately 5 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    The deal value is approximately $9.9bn when including Meda's net debt, which represents a multiple of around 12.9 x 2015 adjusted EBITDA. ... Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    5, 300. Rottapharm/ Meda. Company acquisition . Portfolio of Rx and consumer products.

  • Pharma deals during May 2014 Pharma deals during May 2014

    in Europe, Meda (rejected bid from Mylan), AMco and previously Nycomed (now owned by Takeda).

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    180. GardenHills /. Veropharm. Acquisition. Generic drug manufacture. 151. Acton Pharmaceuticals / Meda.

  • Pharma deals during May 2013 Pharma deals during May 2013

    And, on top of that, at the end of the month there were rumours circulating that the Indian generic company Sun Pharma is seeking to buy Meda for around $5bn. ... Meda's expansion has also been driven by product acquisitions and in the process incurred $2

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Henrik Stenqvist joins Recipharm Henrik Stenqvist joins Recipharm

    Was previously CFO for Meda Group. Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience. ... Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and

  • Virgo makes consumer health changes Virgo makes consumer health changes

    include Durex, Nurofen and Meda Pharma.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...

Quick links